Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI India ETF (INDA) vs Tenet Healthcare Corporation (THC) Price & Performance

iShares MSCI India ETFTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

iShares MSCI India ETF vs Tenet Healthcare Corporation — how do they compare? iShares MSCI India ETF trades at $45.93 (market cap $5.73B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 3.7× iShares MSCI India ETF's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI India ETF for 57 Days and Tenet Healthcare Corporation for 15 Days on average.

INDATHC
Market Cap
$5.73B$20.98B
Volume
6,797,522428,008
Sector
Broad Market / FactorHealth
52-Week High
$55.29$280.77
52-Week Low
$45.42$161.37
Typical Hold Time
57 Days15 Days
Enterprise Value
—$32.06B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI India ETF

INDA is trading at $46.12, down 1.31% with bearish technical signals dominating. The ETF faces headwinds from India's economic challenges including coal power shortages, monsoon concerns, and U.S. tariff tensions. Technical indicators show oversold conditions with RSI readings below 30, while moving averages signal strong bearish momentum. Recent news highlights structural issues in India's banking-heavy market composition despite overall economic growth.

The outlook remains cautious given India's energy security challenges and external trade pressures. Investment opportunity exists for long-term investors betting on India's growth story at current discounted levels, but risks include persistent power shortages, agricultural output concerns, and global trade tensions that could further pressure the ETF's performance.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.

THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDA
3% Buy97% Sell
Avg holding period · 57 Days
THC

No sentiment data available yet.

About iShares MSCI India ETF

INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.

Read more on INDA →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →